+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026

  • ID: 5240207
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • MarketDigits

FEATURED COMPANIES

  • Alkermes
  • ALLERGAN
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Klarisana
  • Merck & Co. Inc
  • MORE
The Psychedelic Drugs Market research report provides an in-depth overview of the industry including market segmentation by drugs, route of administration, distribution channel, end-users, application and geography. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions.
The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter’s analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field.

Market Analysis and Insights: Psychedelic Drugs Market Analysis & Insights

The Psychedelic Drugs Market size is projected to reach USD 10.75 Bn by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.

Psychedelic Drugs Market Scope and Market Size

Psychedelic Drugs market is segmented by region and further by countries, drugs, route of administration, distribution channel, end-users, and application. Players, stakeholders, and other participants in the Global Psychedelic Drugs Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2015-2026.
The research covers the current and historic psychedelic drugs market size and its growth trend with company outline of key players/manufacturers: The Emmes Company, Klarisana, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Pfizer Inc, Mylan N.V. , Merck & Co., Inc, Alkermes, and ALLERGAN among others.
Report further studies the market development status and future of psychedelic drugs market trend across the world. Also, it splits Psychedelic Drugs Market Segmentation by drugs, route of administration, distribution channel, end-users, application and region to deep dive research and reveals market profile and prospects.
Reason to purchase the Psychedelic Drugs Market Report:
  • Determine prospective investment areas based on a detailed trend analysis of the global psychedelic drugs market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different and psychedelic drugs market segments in the top spending countries across the world and identify the opportunities offered by each of them.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global psychedelic drugs market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global psychedelic drugs market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top psychedelic drugs market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.

This report will be delivered within 3-5 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkermes
  • ALLERGAN
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Klarisana
  • Merck & Co. Inc
  • MORE
1. EXECUTIVE SUMMARY

2. INTRODUCTION
2.1. Key Takeaways
2.2. Report Description
2.3. Market Scope & Definition
2.4. Stakeholders
2.5. Research Methodology
2.5.1. Market Size
2.5.2. Key Data Points From Primary Sources
2.5.3. Key Data Points From Secondary Sources
2.5.4. List Of Primary Sources
2.5.5. List Of Secondary Sources

3. MARKET OVERVIEW
3.1. Industry Segmentation
3.2. Market Trends Analysis
3.3. Major Funding & Investments
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Value Chain Analysis
3.6. Pricing Analysis

4. IMPACT OF COVID-19 ON PSYCHEDELIC DRUGS MARKET
4.1. Impact Of Covid-19 On Psychedelic Drugs Market By Drugs
4.2. Impact Of Covid-19 On Psychedelic Drugs Market By Route of Administration
4.3. Impact Of Covid-19 On Psychedelic Drugs Market By Distribution Channel
4.4. Impact Of Covid-19 On Psychedelic Drugs Market By End-Users
4.5. Impact Of Covid-19 On Psychedelic Drugs Market By Application
4.6. Impact Of Covid-19 On Psychedelic Drugs Market By Region

5. PSYCHEDELIC DRUGS MARKET, BY DRUGS
5.1. Introduction
5.2. Lysergic Acid Diethylamide (LSD)
5.3. 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
5.4. Phencyclidine
5.5. Gamma Hydroxybutyric Acid (GHB)
5.6. Ketamine
5.7. Ayahuasca
5.8. Salvia
5.9. Psilocybin
5.10. Others

6. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Oral
6.2. Injectable
6.3. Inhalation

7. PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Direct Retailers
7.2. Online Pharmacies
7.3. Others

8. PSYCHEDELIC DRUGS MARKET, BY END-USERS
8.1. Hospitals
8.2. Homecare
8.3. Specialty Clinics
8.4. Others

9. PSYCHEDELIC DRUGS MARKET, BY APPLICATION
9.1. Major Depressive Disorder
9.2. Resistant depression
9.3. Panic disorder
9.4. Post-traumatic stress disorder
9.5. Opiate Addiction
9.6. Others

10. PSYCHEDELIC DRUGS MARKET, BY GEOGRAPHY
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Rest of Europe
10.3. Asia Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest Of Asia Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa

11. COMPETITIVE ANALYSIS
11.1. Introduction
11.2. Top Companies Ranking
11.3. Market Share Analysis
11.4. Recent Developments
11.4.1. New Product Launch
11.4.2. Mergers & Acquisitions
11.4.3. Collaborations, Partnerships & Agreements
11.4.4. Rewards & Recognition

12. COMPANY PROFILES
12.1. The Emmes Company
12.2. Klarisana
12.3. AstraZeneca
12.4. F. Hoffmann-La Roche Ltd
12.5. Dr. Reddy’s Laboratories Ltd
12.6. Takeda Pharmaceutical Company Limited
12.7. Pfizer Inc
12.8. Mylan N.V.
12.9. Merck & Co., Inc
12.10. Alkermes
12.11. ALLERGAN
Note: Product cover images may vary from those shown
  • The Emmes Company
  • Klarisana
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc
  • Mylan N.V.
  • Merck & Co. Inc
  • Alkermes
  • ALLERGAN
Note: Product cover images may vary from those shown
Adroll
adroll